Malley Thomas
SEC CIK 1403322 · EDGAR
BoughtSold
Most active insiders at KNSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sanj K | COB, CEO, Dir | — | $39.43M |
| 2 | Paolini John F. | Chief MEDICAL Off | — | $8.00M |
| 3 | Ragosa Mark | CFO | — | $5.56M |
| 4 | Tessari Eben | Chief STRATEGY Off | — | $3.10M |
| 5 | Quart Barry D | Dir | — | $2.68M |
| 6 | Megna Michael R | CAO | — | $2.64M |
| 7 | Cole G Bradley | Dir | — | $299.1K |
| 8 | Moat Ross | COO | — | $194.5K |
| 9 | McCain Tracey L | Dir | — | — |
| 10 | Levy Richard S | Dir | — | — |
| 11 | Malley Thomas | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 16:46 | 2026-05-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Malley Thomas | Dir | M - OptEx | — | +2,799 | 15.3K | +22% | — |
| D | 2026-03-20 | 2026-03-18 | KURA | Kura Oncology, Inc. | Malley Thomas | Dir | M - OptEx | $3.12 | +10.0K | 10.0K | New | +$31.2K |
| DM | 2025-08-14 | 2025-08-12+ | KNSA | Kiniksa Pharmaceuticals International, plc | Malley Thomas | Dir | M - OptEx | $10.21 | +177.8K | 62.0K | New | +$1.82M |
| DM | 2025-08-14 | 2025-08-12+ | KNSA | Kiniksa Pharmaceuticals International, plc | Malley Thomas | Dir | S - Sale+OE | $32.96 | -177.8K | 12.5K | -93% | -$5.86M |
| D | 2025-06-05 | 2025-06-05 | KNSA | Kiniksa Pharmaceuticals International, plc | Malley Thomas | Dir | M - OptEx | — | +3,173 | 12.5K | +34% | — |
| D | 2024-06-07 | 2024-06-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Malley Thomas | Dir | M - OptEx | — | +4,373 | 9,373 | +87% | — |
| D | 2023-07-03 | 2023-06-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Malley Thomas | Dir | M - OptEx | — | +5,000 | 5,000 | New | — |
| I | 2023-06-21 | 2023-06-16 | KURA | Kura Oncology, Inc. | Malley Thomas | Dir | P - Purchase | $11.50 | +50.0K | 139.6K | +56% | +$575.0K |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | Malley Thomas | Dir | A - Grant | $0.00 | +12.9K | 46.7K | +38% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | Malley Thomas | Dir | A - Grant | $0.00 | +16.7K | 33.8K | +98% | $0 |
Purchase Sale Sale after option exercise All abbreviations